ATE130370T1 - Verfahren zur expression von, als fusionsproteine produzierten, heterologen proteinen in e. coli, deren verwendungen, expressionsvektoren und rekombinante stämme. - Google Patents

Verfahren zur expression von, als fusionsproteine produzierten, heterologen proteinen in e. coli, deren verwendungen, expressionsvektoren und rekombinante stämme.

Info

Publication number
ATE130370T1
ATE130370T1 AT90202108T AT90202108T ATE130370T1 AT E130370 T1 ATE130370 T1 AT E130370T1 AT 90202108 T AT90202108 T AT 90202108T AT 90202108 T AT90202108 T AT 90202108T AT E130370 T1 ATE130370 T1 AT E130370T1
Authority
AT
Austria
Prior art keywords
proteins
coli
expression
heterologous
heterologue
Prior art date
Application number
AT90202108T
Other languages
English (en)
Inventor
Perez Lidia Ines Novoa
Lahera Jorge A Machado
Maso Julio Raul Fernandez
Conill
Fuentes Jesus V Benitez
Diaz Ramon Emilio Av Narciandi
De Las Vegas Stgo
Reinoso Jose Luis Rodriquez
Versalles
Garcia Mario Pablo Estrada
Suarez Jose Garcia
Martinez Luis Saturnin Herrera
Original Assignee
Cigb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cigb filed Critical Cigb
Application granted granted Critical
Publication of ATE130370T1 publication Critical patent/ATE130370T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT90202108T 1989-08-03 1990-08-02 Verfahren zur expression von, als fusionsproteine produzierten, heterologen proteinen in e. coli, deren verwendungen, expressionsvektoren und rekombinante stämme. ATE130370T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU89149A CU22222A1 (es) 1989-08-03 1989-08-03 Procedimiento para la expresion de proteinas heterologicas producidas de forma fusionada en escherichia coli, su uso, vectores de expresion y cepas recombinantes

Publications (1)

Publication Number Publication Date
ATE130370T1 true ATE130370T1 (de) 1995-12-15

Family

ID=5459457

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90202108T ATE130370T1 (de) 1989-08-03 1990-08-02 Verfahren zur expression von, als fusionsproteine produzierten, heterologen proteinen in e. coli, deren verwendungen, expressionsvektoren und rekombinante stämme.

Country Status (6)

Country Link
EP (1) EP0416673B1 (de)
JP (1) JPH04158797A (de)
AT (1) ATE130370T1 (de)
CU (1) CU22222A1 (de)
DE (1) DE69023580T2 (de)
ES (1) ES2081913T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4002636A1 (de) * 1990-01-30 1991-08-01 Boehringer Mannheim Gmbh Expression von hiv1- und 2-polypeptiden und deren verwendung
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
US6168785B1 (en) * 1998-07-16 2001-01-02 Institut Pasteur Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents
US6929791B2 (en) 1998-07-16 2005-08-16 Institut Pasteur Peptides of IL-2 and derivatives thereof
IL142539A0 (en) * 1998-10-16 2002-03-10 Immunex Corp Inhibitors of platelet activation and recruitment
US7264809B1 (en) 1998-10-16 2007-09-04 Immunex Corporation Methods of inhibiting platelet activation and recruitment
US6926898B2 (en) 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
US6946134B1 (en) 2000-04-12 2005-09-20 Human Genome Sciences, Inc. Albumin fusion proteins
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
CN1255548C (zh) 2001-06-15 2006-05-10 霍夫曼-拉罗奇有限公司 gp41片段的乙酰化
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
CA2841097A1 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin and g-csf fusion proteins
WO2007141650A2 (en) * 2006-01-17 2007-12-13 Instituto De Medicina Molecular Compositions and methods for diagnosing hiv-2 infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636903A1 (de) * 1985-12-21 1987-07-02 Hoechst Ag Fusionsproteine mit eukaryotischem ballastanteil
DE3541856A1 (de) * 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens
ES2054616T3 (es) * 1985-12-17 1994-08-16 Akzo Nv Reactivo inmunoquimico.
EP0345792A3 (de) * 1988-06-10 1991-05-02 F. Hoffmann-La Roche Ag HTLV-1/HIV-1-Fusionsproteine

Also Published As

Publication number Publication date
CU22222A1 (es) 1995-01-31
JPH04158797A (ja) 1992-06-01
EP0416673A1 (de) 1991-03-13
DE69023580T2 (de) 1996-04-11
ES2081913T3 (es) 1996-03-16
EP0416673B1 (de) 1995-11-15
DE69023580D1 (de) 1995-12-21

Similar Documents

Publication Publication Date Title
EA199700244A1 (ru) Слитый белок, экспрессирующий вектор, рекомбинантный штамм, вакцинный препарат
DE69023580D1 (de) Verfahren zur Expression von, als Fusionsproteine produzierten, heterologen Proteinen in E. coli, deren Verwendungen, Expressionsvektoren und rekombinante Stämme.
KR950000300B1 (ko) 융합 단백질의 제조방법
CA2195799C (en) Bacterial production of hydrophobic polypeptides
DE3584053D1 (de) Gentechnologisches verfahren zur herstellung von hirudinen und mittel zur durchfuehrung dieses verfahrens.
EP0722461A4 (de) Expression eines fusionspolypeptides, das ohne leadersequenz aus dem cytoplasma transportiert wird
MX9702714A (es) Produccion de peptidos en plantas como fusiones de proteinas con revestimiento viral.
ATE169959T1 (de) Anthrax-toxin-fusionsproteine und deren verwendungen
DK0955313T3 (da) Nyt protein og fremgangsmåde til fremstilling af samme
DE3650625D1 (de) AraB-Promoter und Verfahren zur Herstellung von Polypeptiden einschliesslich Cecropinen mittels mikrobiologischer Verfahren
DE69034100D1 (de) Verktorvermittelte genominsertion und expression von dna in bcg
TR27970A (tr) Bitki kofulu icine hedeflemede kullanilan yeni sinyal dizimleri.
NO902251L (no) Fremstilling av gonoreiske p1-proteiner og vaksiner.
DE69233245D1 (de) Verfahren zur Herstellung von Peptiden
DK0652903T3 (da) Nyt humant rekombinant gammainterferon
ATE53606T1 (de) Mit einem herpes-simplex-virus-gen inseriertes rekombinantes plasmid.
ITMI910314A1 (it) Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressione di detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine rico
WO1995008628A3 (en) Nucleic acids encoding merosin, merosin fragments and uses thereof
ATE43139T1 (de) Klonierungs- und expressionsvektoren fuer gammainterferon, transformierte bakterien und verfahren zur herstellung von gamma-interferon.
Sieg et al. A versatile phage lambda expression vector system for cloning in Escherichia coli
Sedláček et al. Processed enzymatically active protease (p15 gag) of avian retrovirus obtained in an E. coli system expressing a recombinant precursor (Pr25 lac‐Δgag)
Sekine et al. Expression of HTLV-I gag protein in Escherichia coli
Ito et al. Expression and secretion of human epidermal growth factor in Escherichia coli
NO902491D0 (no) Proteiner, vaksiner og nukleinsyrer.
ES2120409T3 (es) Nuevos vectores de expresion y metodos para la produccion de proteinas intracelulares.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee